851 related articles for article (PubMed ID: 28065190)
1. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
2. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
Fisk CM; Theobald HE; Sanders TA
J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
[TBL] [Abstract][Full Text] [Related]
3. Dietary calcium does not interact with vitamin D₃ in terms of determining the response and catabolism of serum 25-hydroxyvitamin D during winter in older adults.
Cashman KD; Hayes A; O'Donovan SM; Zhang JY; Kinsella M; Galvin K; Kiely M; Seamans KM
Am J Clin Nutr; 2014 Jun; 99(6):1414-23. PubMed ID: 24695896
[TBL] [Abstract][Full Text] [Related]
4. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
[TBL] [Abstract][Full Text] [Related]
5. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
6. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome.
Sansanayudh N; Wongwiwatthananukit S; Phetkrajaysang N; Krittiyanunt S
Int J Clin Pharm; 2014 Aug; 36(4):771-8. PubMed ID: 24853094
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
9. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
Stubbs JR; Zhang S; Friedman PA; Nolin TD
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
[TBL] [Abstract][Full Text] [Related]
10. The change in plasma 25-hydroxyvitamin D did not differ between breast-fed infants that received a daily supplement of ergocalciferol or cholecalciferol for 3 months.
Gallo S; Phan A; Vanstone CA; Rodd C; Weiler HA
J Nutr; 2013 Feb; 143(2):148-53. PubMed ID: 23256143
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach.
Oliveri B; Mastaglia SR; Brito GM; Seijo M; Keller GA; Somoza J; Diez RA; Di Girolamo G
Eur J Clin Nutr; 2015 Jun; 69(6):697-702. PubMed ID: 25782422
[TBL] [Abstract][Full Text] [Related]
13. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis.
Cipriani C; Romagnoli E; Pepe J; Russo S; Carlucci L; Piemonte S; Nieddu L; McMahon DJ; Singh R; Minisola S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2709-15. PubMed ID: 23766519
[TBL] [Abstract][Full Text] [Related]
14. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases.
Stokes CS; Volmer DA
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1311-1317. PubMed ID: 27863206
[TBL] [Abstract][Full Text] [Related]
15. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD
Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
Aterrado S; Ono G; Kanehira-Mar S; Meier J; Swislocki A
Ann Pharmacother; 2015 Sep; 49(9):969-77. PubMed ID: 26104054
[TBL] [Abstract][Full Text] [Related]
18. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.
Romagnoli E; Mascia ML; Cipriani C; Fassino V; Mazzei F; D'Erasmo E; Carnevale V; Scillitani A; Minisola S
J Clin Endocrinol Metab; 2008 Aug; 93(8):3015-20. PubMed ID: 18492750
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
Khazai NB; Judd SE; Jeng L; Wolfenden LL; Stecenko A; Ziegler TR; Tangpricha V
J Clin Endocrinol Metab; 2009 Jun; 94(6):2037-43. PubMed ID: 19336509
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D3 supplementation in healthy adults: a comparison between capsule and oral spray solution as a method of delivery in a wintertime, randomised, open-label, cross-over study.
Todd JJ; McSorley EM; Pourshahidi LK; Madigan SM; Laird E; Healy M; Magee PJ
Br J Nutr; 2016 Oct; 116(8):1402-1408. PubMed ID: 27724992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
